Evidence map›Paper›PMID 36140507›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Validation of Three MicroScan

Jean-Baptiste Ronat, Saoussen Oueslati, Alessandra Natale, Thomas Kesteman, Wael Elamin, Céline Langendorf, Liselotte Hardy, Olivier Vandenberg, Thierry Naas

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

Jean-Baptiste RonatMédecins Sans Frontières, 75019 Paris, France.ORCID 0000-0002-4165-7215
Saoussen OueslatiTeam ReSIST, INSERM U1184, School of Medicine University Paris-Saclay, 94270 Le Kremlin-Bicêtre, France.ORCID 0000-0001-5766-3831
Alessandra NataleMédecins Sans Frontières, 75019 Paris, France.
Thomas KestemanOxford University Clinical Research Unit, Hanoi 10000, Vietnam.ORCID 0000-0002-7951-8261
Wael ElaminInstitute of Health Science Education, Queen Mary University, London CB105, UK.ORCID 0000-0003-2590-6274
Céline LangendorfEpicentre, 75019 Paris, France.
Liselotte HardyUnit Tropical Bacteriology, Department of Clinical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.ORCID 0000-0002-8785-5081
Olivier VandenbergCenter for Environmental Health and Occupational Health, School of Public Health, Université Libre de Bruxelles (ULB), 1050 Brussels, Belgium.
Thierry NaasTeam ReSIST, INSERM U1184, School of Medicine University Paris-Saclay, 94270 Le Kremlin-Bicêtre, France.ORCID 0000-0001-9937-9572
Inserm · FRInstituut voor Tropische Geneeskunde · BEMédecins Sans Frontières · FROxford University Clinical Research Unit · VNQueen Mary University of London · GBUniversité Libre de Bruxelles · BE

Funding

Médecins Sans Frontières STATIC001
6 · The paper itself

Abstract

Easy and robust antimicrobial susceptibility testing (AST) methods are essential in clinical bacteriology laboratories (CBL) in low-resource settings (LRS). We evaluated the Beckman Coulter MicroScan lyophilized broth microdilution panel designed to support Médecins Sans Frontières (MSF) CBL activity in difficult settings, in particular with the Mini-Lab. We evaluated the custom-designed MSF MicroScan Gram-pos microplate (MICPOS1) for

Indexed as

antibiotic susceptibility testingclinical bacteriologylow-resource settingsMicroScan

Identifiers

PMID36140507
PMCPMC9497938
OpenAlexW4293776622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.